Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
Release Date:
Partner: Sumitomo Pharma
Review Process: Pfizer Internal
Education Oncology USA
Title
Grant Type
Focus Area
Country
Application Due Date
Addressing Healthcare Disparities in the Recognition, Early Diagnosis and Treatment of Primary Immunodeficiencies
Release Date:
Review Process: Pfizer Internal
Education Hospital USA
Knowledge Gaps in the Prevention of COVID-19 in Europe
Release Date:
Review Process: Pfizer Internal
Education Vaccines All
Hemophilia: Improving Knowledge of Novel Hemophilia Therapies Amongst Multidisciplinary Teams
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA
Optimizing Androgen Deprivation Therapy (ADT) in Advanced Prostate Cancer
Release Date:
Partner: Myovant Sciences
Review Process: Pfizer Internal
Education Oncology USA
Quality of Care Initiative to Improve the Treatment of Advanced or Metastatic Bladder Cancer Patients
Release Date:
Partner: NCCN, EMD Serono
Review Process: Expert Review Panel
Quality Improvement Oncology USA
Educational Projects for Healthcare Professionals to Promote Cancer Patient Support
Release Date:
Partner: Japan Society of Clinical Oncology
Review Process: Expert Review Panel
Education Oncology Japan
Latin America Needs Assessment of Prostate Cancer
Release Date:
Review Process: Pfizer Internal
Education Oncology All
Menopause and Mental Health
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine USA
Efforts to Promote an Environmental Improvement for Cancer Genomic Medicine
Release Date:
Partner: Japan Society of Clinical Oncology
Review Process: Expert Review Panel
Education Oncology Japan
Understanding of Biosimilars and Shared Decision Making including Financial Burden in Cancer Treatment
Release Date:
Review Process: Pfizer Internal
Education Oncology Japan
Review and analysis of retrospective, local source, serotype distribution for invasive pneumococcal disease
Release Date:
Review Process: Pfizer Internal
Research Vaccines Hong Kong, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam
Addressing Diagnostic Challenges for Non-Alcoholic Steatohepatitis (NASH)
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine All